Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Peplin Ltd.

Division of Leo Pharma AS
www.peplin.com

Latest From Peplin Ltd.

Dermira raises $35m in series B

Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.

Dermatology Japan

Leo Pharma Aims To Extend Reach Of Dermatology Business With Global Expansion And Picato’s Green Light For Europe

Danish dermatology specialist Leo Pharma is hunting for new pipeline assets after its next major product – Picato gel – got the green light from Europe’s top regulator.

BioPharmaceutical Europe

LEO Plays Up Rapid Action Of Picato For Actinic Keratosis

Newly approved plant-based gel works in just a few days of treatment, rather than the weeks required for some competitors.

BioPharmaceutical

Dermatology startup Dermira raises $42M in Series A and acquires Valocor Therapeutics

Dermira Inc, a new company focusing on the dermatology arena including an early-stage acne therapy candidate, has raised $42 million in a Series A round, which includes existing investor Bay City Capital, along with New Enterprise Associates and Canaan Partners. In conjunction with the fund raising, Dermira has acquired the dermatology company Velocor Therapeutics for an undisclosed sum, and it will continue to seek out other dermatological assets for licensing or acquisition.

Dermatology
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
  • Therapeutic Areas
  • Cancer
  • Dermatology
  • Alias(es)
  • Peplin Biotech Ltd.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Australia
  • Parent & Subsidiaries
  • Leo Pharma AS
  • Senior Management
  • Michael Aldridge, CEO
    Philip Moody, VP, Fin. & Operations & CFO
    Arthur P Bertolino, MD, PhD, VP, Medical Affairs & CMO
    George Mahaffey, Chief Comm. Officer & VP, Sales & Mktg.
  • Contact Info
  • Peplin Ltd.
    Phone: (61) 7 3250 1200
    1 Breakfast Creek Rd.
    Newstead, QLD 4006
    Australia
Advertisement
Advertisement
UsernamePublicRestriction

Register